Navigation Links
Pharmexa in Medical Technology

Pharmexa A/S (DK) - Pharmexa presents data from influenza program

Summary: Pharmexa-Epimmune, the U.S.-based subsidiary of Pharmexa A/S, presents selected data from its influenza vaccine program today at the Influenza Conference entitled, "Options for the Control of Influenza VI," held in Toronto, Ontario, Canada. The data show that a "universal" vaccine designe...

Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine

...with low royalty stacking. The Company has concluded deals with commercial organizations such as Peregrine, XOMA, NatImmune, Viventia, Dyax, Micromet, pharmexa and others. Further information at www.affitech.com. Contact Affitech (Norway) Dr. Martin Welschof Chief Executive Officer +47 22 95 87 58 <...

Pharmexa A/S (DK) - Long lasting immune response and survival to RAS vaccine

...f Executive Officer, telephone +45 4516 2525 Claude Mikkelsen, Head of Investor Relations, telephone +45 4516 2525 or +45 4060 2558 Note to editors: pharmexa A/S is a leading company in the field of active immunotherapy and vaccines for the treatment of cancer, serious chronic and infectious diseases. Pharm...
Pharmexa in Biological Technology

Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech

... Affitech A/S is an antibody research and development company. It was formed recently by a reverse merger of Norway, Oslo-based Affitech AS with pharmexa A/S, a Danish biotech company. The merged company has developed several proprietary technology platforms that constitute a highly productive, fully h...

Pharmexa and Affitech to Combine Operations to Create a New Antibody Therapeutics Company

... COPENHAGEN and OSLO, March 4 /PRNewswire/ -- pharmexa A/S and Affitech AS announced today that they have...anies by means of a share for share acquisition by pharmexa A/S of the private Norwegian company, Affitech AS. The purpose of the merger is to transform pharmexa from a cancer and infectious disease vaccine busin...

Affitech Acquires Pharmexa's Diabody Technology

...ndidates for a variety of therapeutic applications. The acquisition follows an exclusive license of the diabody IP that Affitech obtained in 2007 from pharmexa to carry out certain non-clinical GLP compliant studies, as well as sub-licensing arrangements with third parties. Affitech CEO Martin Welschof comm...

Affitech Announces Second Milestone in Roche Antibody Discovery Collaboration

...y stacking. The Company has concluded deals with commercial organizations such as Omeros, Roche, Peregrine, XOMA, NatImmune, Viventia, Dyax, Micromet, pharmexa and others. Further information at http://www.affitech.com . Contacts for Affitech: Affitech (Norway): Dr. Martin Welschof Chief Executive Off...

Affitech Appoints Dr. Keith McCullagh as Chairman

...y stacking. The Company has concluded deals with commercial organizations such as Roche, Peregrine, Omeros, XOMA, NatImmune, Viventia, Dyax, Micromet, pharmexa and others. Further information at http://www.affitech.com . About Keith McCullagh Keith McCullagh, PhD, BVSc, MRCVS, is an experienced bioscienc...

Emergence of Cancer Vaccines Will Be the Key Factor Driving the Pancreatic Cancer Drug Market to More Than Double by 2016

...orld's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the emergence of cancer vaccines, including drugs from pharmexa and Cell Genesys, will be the key factor driving the pancreatic cancer drug market to more than double by 2016. The new Pharmacor report entitled Pan...
Other Tags
(Date:7/28/2014)... Steven Reinberg HealthDay ... People who have dementia and heart rhythm irregularities are more ... research has found. In fact, the study of more ... to 80 percent more likely to get a pacemaker than ... from this study is why folks with dementia are so ...
(Date:7/28/2014)... 2014 Parker Waichman LLP, a personal injury ... that the heroes of 9/11 are never forgotten, comments that ... important deadline. According to a VCF message dated ... cancer on or before October 12, 2012 must file a ... and others who were allegedly injured by the toxic dust ...
(Date:7/28/2014)... the meal you,ve ordered at a restaurantor when ... through your brain. , These waves are ... of cellsboth excitatory and inhibitoryplaying together in an ... gamma waves have been associated with higher-level brain ... tied to schizophrenia, Alzheimer,s disease, autism, epilepsy and ...
(Date:7/28/2014)... two dopamine-producing regions in the brain was able to ... propofol. In the August issue of Anesthesiology ... rats anesthetized with continuous doses of either agent would ... response to electrical stimulation delivered to the ventral tegmental ... area, the substantia nigra, did not induce the animals ...
(Date:7/28/2014)... Lourdes Health System has partnered with a ... times for veterans needing medical care. , Lourdes is ... the only one in Camden, Burlington and Gloucester counties—participating ... (PC3). PC3 gives veterans access to specialty care when ... due to lack of available specialists, long wait times ...
Breaking Medicine News(10 mins):Health News:Pacemakers Common for Those With Dementia and Irregular Heartbeats 2Health News:Pacemakers Common for Those With Dementia and Irregular Heartbeats 3Health News:October 12, 2014 Deadline Approaching for 9/11 First Responders Suffering from Certain Cancers to Submit Their Registration to the VCF, Parker Waichman LLP Comments 2Health News:October 12, 2014 Deadline Approaching for 9/11 First Responders Suffering from Certain Cancers to Submit Their Registration to the VCF, Parker Waichman LLP Comments 3Health News:Memory relies on astrocytes, the brain's lesser known cells 2Health News:Memory relies on astrocytes, the brain's lesser known cells 3Health News:Stimulation of brain region restores consciousness to animals under general anesthesia 2Health News:Lourdes Expands Military Partnership with Veterans 2Health News:Lourdes Expands Military Partnership with Veterans 3
(Date:7/28/2014)... team of researchers led by the University of Arizona ... The genetic information will enhance scientists, and agriculturalists, understanding ... as enable the development of new rice varieties that ... to help solve global hunger challenges. , The paper, ... ) and evidence for independent domestication," was published online ...
(Date:7/28/2014)... and organic compounds in hydrothermal environments are critical components ... for the deep biosphere, and may have implications for ... about how minerals influence organic reactions. A team ... a common mineral acts as a catalysts for specific ... solvents or expensive reagents. , At the heart of ...
(Date:7/28/2014)... Researchers at Yale School of Medicine have pinpointed a mechanism ... glucose levels in the blood, linking it to both type ... the July 28 issue of Proceedings of the National ... prolyl endopeptidase enzyme located in a part of the ... of steps in motion that control glucose levels in the ...
Breaking Biology News(10 mins):Generating a genome to feed the world: UA-led team sequences African rice 2Generating a genome to feed the world: UA-led team sequences African rice 3Generating a genome to feed the world: UA-led team sequences African rice 4Mineral magic? Common mineral capable of making and breaking bonds 2Mineral magic? Common mineral capable of making and breaking bonds 3Glucose 'control switch' in the brain key to both types of diabetes 2
Other Contents